Compounds > homocysteine

homocysteine and Activated Protein C Resistance

homocysteine has been researched along with Activated Protein C Resistance in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (10.00)18.2507
2000's13 (65.00)29.6817
2010's5 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belfeki, N; Houman, MH; Khanfir, MS; Said, F1
Irkec, M; Mocan, MC; Orhan, M; Sekeroglu, MA1
Al-Fadhli, SM; Al-Humood, S; Marouf, R; Mojiminiyi, O; Mustafa, NY1
Antonakos, G; Armaganidis, A; Bagos, P; Dima, K; Dimopoulou, I; Kapsimali, V; Kopterides, P; Nikolopoulos, G; Travlou, A; Tsangaris, I; Tsantes, A; Vrioni, G1
Bern, M; McCarthy, N1
Adamek, L; Domagala, TB; Nizankowska, E; Sanak, M; Szczeklik, A1
Chang, NS; Cho, CS; Chung, SY; Kang, MS; Kim, NK; Kim, SH; Na, BW; Oh, D; Park, S1
Ridker, PM1
Houston, DS; Zarychanski, R1
Hartnett, ME; Laposata, M; Van Cott, EM1
Duschek, EJ; Neele, SJ; Netelenbos, C; Rosing, J; Thomassen, MC1
Tripodi, A1
Marpeau, L; Verspyck, E1
Mahmood, A; Mahy, G; Mainwaring, J; Needham, J; Prosser, J; Ramage, J; Trebble, T1
Abdella, N; Al Humood, S; Al Mazeedy, M; Al Wazzan, H; Marouf, R; Mojiminiyi, O; Qurtom, M1
Blair, AJ; Dumenco, LL; Sweeney, JD1
Sacher, RA1
Blom, HJ; Eskes, TK; Monnens, LA; Nováková, I; van der Molen, EF; Verbruggen, B1
Friedler, S; Kornberg, Y; Raziel, A; Ron-El, R; Schachter, M; Sela, BA1
Johnson, RN; Kearney, J; Koo, H; Lahey, JM; Modlinski, B; Tanaka, S; Tunç, M1

Reviews

4 review(s) available for homocysteine and Activated Protein C Resistance

ArticleYear
Inherited risk factors for venous thromboembolism: implications for clinical practice.
    Clinical cornerstone, 2002, Volume: 4, Issue:6

    Topics: Activated Protein C Resistance; Anticoagulants; Factor V; Homocysteine; Humans; Models, Statistical; Point Mutation; Prevalence; Prothrombin; Recurrence; Risk Factors; Thromboembolism; Venous Thrombosis

2002
A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia.
    Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:1

    Topics: Activated Protein C Resistance; Antithrombins; Chemistry, Clinical; Factor V; Fibrinogens, Abnormal; Genotype; Hematology; Homocysteine; Humans; Mutation; Protein C; Protein S; Prothrombin; Reproducibility of Results; Thrombophilia

2005
[Thrombophilias and vascular placental pathology. A survey of the literature].
    La Revue de medecine interne, 2005, Volume: 26, Issue:2

    Topics: Activated Protein C Resistance; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Cohort Studies; Confidence Intervals; Drug Therapy, Combination; Female; Fetal Death; Fetal Growth Retardation; Forecasting; Homocysteine; Humans; Infant, Newborn; Meta-Analysis as Topic; Multivariate Analysis; Odds Ratio; Placenta; Placenta Diseases; Platelet Aggregation Inhibitors; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Prospective Studies; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis

2005
Thrombophilia: a genetic predisposition to thrombosis.
    Transactions of the American Clinical and Climatological Association, 1999, Volume: 110

    Topics: Activated Protein C Resistance; Antithrombins; Fibrinolysis; Homocysteine; Humans; Mutation; Protein C Deficiency; Protein S Deficiency; Prothrombin; Risk Factors; Thromboembolism; Thrombophilia; Thrombosis

1999

Trials

2 trial(s) available for homocysteine and Activated Protein C Resistance

ArticleYear
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:8

    Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor V; Female; Homocysteine; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride

2004
Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.
    BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:6

    Topics: Activated Protein C Resistance; Adult; Antithrombin III; Case-Control Studies; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Mutation; Placenta; Placenta Diseases; Pregnancy; Protein C; Protein S; Risk Factors; Tetrahydrofolates; Thrombosis

2000

Other Studies

14 other study(ies) available for homocysteine and Activated Protein C Resistance

ArticleYear
[Thrombophilia in systemic lupus erythematosus: A case-control study].
    Journal de medecine vasculaire, 2018, Volume: 43, Issue:6

    Topics: Activated Protein C Resistance; Adult; Antibodies, Anticardiolipin; beta 2-Microglobulin; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Female; Homocysteine; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Protein C Deficiency; Thrombosis

2018
Hereditary Thrombophilic Factors in Glaucoma.
    Journal of glaucoma, 2016, Volume: 25, Issue:2

    Topics: Activated Protein C Resistance; Aged; Aged, 80 and over; Antithrombin III; Blood Coagulation Factors; Case-Control Studies; Exfoliation Syndrome; Factor V; Female; Glaucoma, Open-Angle; Homocysteine; Humans; Intraocular Pressure; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prospective Studies; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia

2016
Hypercoagulable state and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with beta-thalassemia major in Kuwait.
    Acta haematologica, 2010, Volume: 123, Issue:1

    Topics: Activated Protein C Resistance; Adolescent; Adult; Antithrombins; Base Sequence; beta-Thalassemia; Blood Coagulation Disorders; Case-Control Studies; DNA Primers; Female; Heterozygote; Homocysteine; Homozygote; Humans; Kuwait; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Protein C; Protein S; Risk Factors; Thromboembolism; Young Adult

2010
The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis.
    Minerva anestesiologica, 2010, Volume: 76, Issue:10

    Topics: Activated Protein C Resistance; Aged; Blood Coagulation Tests; Cohort Studies; Comorbidity; Factor V; Female; Folic Acid; Homocysteine; Homocystinuria; Hospital Mortality; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Muscle Spasticity; Point Mutation; Protein C; Psychotic Disorders; Respiration, Artificial; Sepsis; Shock, Septic; Thrombophilia; Vitamin B 12

2010
Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1

    Topics: Activated Protein C Resistance; Antibodies, Anticardiolipin; Antithrombin III; Biomarkers; Blood Coagulation Factors; Diagnostic Tests, Routine; Factor V; Homocysteine; Humans; Plasminogen Activator Inhibitor 1; Preoperative Care; Protein C; Recurrence; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism

2013
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:5

    Topics: 3' Untranslated Regions; Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Codon; Factor V; Fasting; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Poland; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis

2002
Acquired activated protein C resistance, high tissue factor expression, and hyper-homocysteinemia in systemic lupus erythematosus.
    American journal of hematology, 2003, Volume: 72, Issue:2

    Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Prevalence; Retrospective Studies; Thromboembolism; Thromboplastin; Thrombosis

2003
Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulability.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:6

    Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Factor V; Female; Homocysteine; Humans; Infant; Infant, Newborn; Male; Middle Aged; Models, Biological; Protein C; Regression Analysis; Retrospective Studies; Thrombophilia

2004
Prothrombin gene mutation G20210A, homocysteine, antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:5

    Topics: Activated Protein C Resistance; Aged; Antibodies, Anticardiolipin; Child; Eye Diseases; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Coagulation Inhibitor; Male; Middle Aged; Point Mutation; Protein C; Prothrombin; Thrombosis

2004
Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
    European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:7

    Topics: Activated Protein C Resistance; Adult; Colitis, Ulcerative; Crohn Disease; Factor V; Factor VIII; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Inflammatory Bowel Diseases; Male; Middle Aged; Mutation; Protein C; Prothrombin; Vitamin B 12

2005
Plasma homocysteine and hematological factors in patients with venous thromboembolic diseases in Kuwait.
    Acta haematologica, 2007, Volume: 117, Issue:2

    Topics: Activated Protein C Resistance; Adult; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kuwait; Male; Protein C; Protein S; Thromboembolism; Venous Thrombosis

2007
The results of diagnostic studies for thrombophilia in a large group of patients with a personal or family history of thrombosis.
    American journal of clinical pathology, 1998, Volume: 110, Issue:5

    Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Child; Child, Preschool; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Lupus Coagulation Inhibitor; Middle Aged; Mutation; Thrombophilia; Thrombophlebitis; Thrombosis

1998
Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2001, Volume: 45, Issue:2

    Topics: Abortion, Habitual; Activated Protein C Resistance; Adult; Factor V; Female; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Pregnancy; Thrombophilia

2001
Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age.
    Ophthalmology, 2002, Volume: 109, Issue:1

    Topics: Activated Protein C Resistance; Adult; Blood Cell Count; Blood Glucose; Blood Pressure; Factor V; Female; Homocysteine; Humans; Intraocular Pressure; Lipids; Lupus Coagulation Inhibitor; Male; Middle Aged; Prospective Studies; Protein C; Protein S; Retinal Vein Occlusion; Retrospective Studies; Thrombophilia

2002